RXO (NYSE:RXO) Stock Price Up 8.4% – Should You Buy?

Rxo Inc (NYSE:RXOGet Free Report)’s stock price traded up 8.4% during mid-day trading on Wednesday . The company traded as high as $17.22 and last traded at $17.2840. 1,520,410 shares traded hands during mid-day trading, a decline of 17% from the average session volume of 1,839,015 shares. The stock had previously closed at $15.94.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Morgan Stanley upgraded RXO from an “equal weight” rating to an “overweight” rating and set a $19.00 price objective for the company in a research report on Tuesday, November 11th. Wolfe Research raised RXO from an “underperform” rating to a “peer perform” rating in a report on Friday, November 14th. Citigroup reduced their price target on shares of RXO from $16.00 to $15.00 and set a “neutral” rating on the stock in a research report on Thursday, January 8th. Zacks Research cut shares of RXO from a “hold” rating to a “strong sell” rating in a research report on Friday, January 9th. Finally, The Goldman Sachs Group dropped their target price on shares of RXO from $17.00 to $15.00 and set a “neutral” rating for the company in a research note on Thursday, October 9th. Four investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $16.14.

Get Our Latest Research Report on RXO

RXO Price Performance

The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.32 and a current ratio of 1.32. The company has a 50-day moving average price of $14.20 and a 200-day moving average price of $15.17. The firm has a market capitalization of $2.80 billion, a P/E ratio of -39.72, a price-to-earnings-growth ratio of 7.57 and a beta of 1.74.

RXO (NYSE:RXOGet Free Report) last released its earnings results on Thursday, November 6th. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.02). The company had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.44 billion. RXO had a negative net margin of 1.25% and a positive return on equity of 0.88%. The company’s quarterly revenue was up 34.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.05 EPS. On average, sell-side analysts predict that Rxo Inc will post 0.31 earnings per share for the current year.

Insider Buying and Selling at RXO

In other RXO news, CEO Andrew M. Wilkerson acquired 7,775 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The shares were acquired at an average price of $12.88 per share, with a total value of $100,142.00. Following the purchase, the chief executive officer owned 7,775 shares of the company’s stock, valued at $100,142. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Troy A. Cooper bought 8,317 shares of the firm’s stock in a transaction on Thursday, November 20th. The stock was acquired at an average cost of $10.61 per share, with a total value of $88,243.37. Following the completion of the purchase, the director owned 275,416 shares of the company’s stock, valued at approximately $2,922,163.76. This trade represents a 3.11% increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders bought 40,250 shares of company stock valued at $488,875. Corporate insiders own 2.80% of the company’s stock.

Institutional Investors Weigh In On RXO

A number of hedge funds have recently modified their holdings of RXO. Orbis Allan Gray Ltd grew its position in shares of RXO by 3.8% in the 2nd quarter. Orbis Allan Gray Ltd now owns 31,375,221 shares of the company’s stock valued at $493,218,000 after purchasing an additional 1,142,710 shares during the period. Vanguard Group Inc. boosted its holdings in shares of RXO by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 17,309,811 shares of the company’s stock valued at $218,796,000 after buying an additional 93,130 shares during the period. Wellington Management Group LLP boosted its holdings in shares of RXO by 7.9% in the third quarter. Wellington Management Group LLP now owns 9,998,681 shares of the company’s stock valued at $153,780,000 after buying an additional 735,810 shares during the period. Finepoint Capital LP bought a new stake in shares of RXO during the third quarter worth $111,764,000. Finally, State Street Corp raised its holdings in shares of RXO by 1.5% during the second quarter. State Street Corp now owns 5,821,207 shares of the company’s stock worth $91,509,000 after acquiring an additional 85,405 shares during the period. Institutional investors and hedge funds own 92.73% of the company’s stock.

About RXO

(Get Free Report)

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.

Featured Stories

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.